DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 19 May · 11:41 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has filed copies of newspaper clippings regarding its audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. These results were approved by the Board of Directors at their meeting held on May 17, 2025, based on the recommendation of the Audit Committee. The newspaper advertisements were published on May 18, 2025 in Financial Express (English, all editions) and Andhra Prabha (Telugu, Hyderabad edition). The filing is being made under SEBI Listing Regulations (Regulation 47) as a compliance requirement. No specific financial figures are disclosed in this filing, as it only serves to submit the published newspaper clippings.

Likely market impact

This is a routine regulatory compliance submission and contains no new information beyond what was already disclosed when the Board approved results on May 17, 2025. Retail investors should look at the original results filing from May 17 for actual financial performance. No direct stock price impact expected from this filing alone.